NCT03703349View on ClinicalTrials.gov

Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 24, 2018

Primary Completion Date

October 20, 2019

Study Completion Date

October 20, 2019

Conditions

Atrial FibrillationCoronary Artery DiseaseSurgery--Complications

Interventions

DRUG

Magnesium Sulfate

Magnesium sulfate will be prescribed by the surgeon / Anesthesiologist and will be taken orally by the patient for the 3 days preceding the surgery

DRUG

Placebo Oral Tablet

Placebo for Magnesium

Trial Locations (1)

166830

Hotel Dieu de France, Beirut

All Listed Sponsors

lead

St Joseph University, Beirut, Lebanon

OTHER

NCT03703349 - Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS) | Biotech Hunter | Biotech Hunter